Search - tctmd.com

Displaying 161 - 180 of 378

Sort: Relevancy | Date

News Daily News

FDA Approves Finerenone for Adults With CKD and Type 2 Diabetes

Yael L. Maxwell

July 09, 2021

News Daily News

Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results

Todd Neale

July 06, 2021

News Daily News

Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA

L.A. McKeown

June 23, 2021

News Daily News

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Michael O'Riordan

June 16, 2021

News Daily News

First PCIs Preceded by Many Modifiable Risk Factors: Registry Data

L.A. McKeown

June 16, 2021

News Opinion CV Team Dispatch

June 2021 News Roundup

L.A. McKeown

June 01, 2021

News Daily News

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Shelley Wood

May 27, 2021

News Daily News

Finerenone Cuts CV Events in CKD Patients With Diabetes: FIGARO-DKD

Michael O'Riordan

May 11, 2021

News Conference News ACC 2021

Prediabetes Linked to Higher MACE Risk

Todd Neale

May 10, 2021

News Conference News ACC 2021

Social Determinants of Health Tied to Fewer COVID-19 Precautions in CVD Patients

Caitlin E. Cox

May 07, 2021

News Conference News SCAI 2021

In African-American Patients, Nontraditional Risk Factors Track With Early CAD

Michael O'Riordan

April 28, 2021

News Daily News

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Michael O'Riordan

April 26, 2021

News Daily News

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Michael O'Riordan

April 02, 2021

News Daily News

AHA Seeks to Drive Down Amputations 20% by 2030

L.A. McKeown

April 01, 2021

News Daily News

Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk

Michael O'Riordan

March 23, 2021

News Daily News

Little Improvement Seen Over Two Decades in US Racial Health Disparities

L.A. McKeown

March 15, 2021

News Daily News

Cardiometabolic Diseases Contribute to Bulk of COVID-19 Hospitalizations

Todd Neale

March 04, 2021

News Daily News

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Michael O'Riordan

March 03, 2021

News Daily News

High Glycemic Index Diets Linked to CVD and Mortality

Michael O'Riordan

February 24, 2021

News Daily News

Mom’s CV Health in Pregnancy Foretells Child’s Risk Years Later

L.A. McKeown

February 17, 2021

Advertisement

FDA Approves Finerenone for Adults With CKD and Type 2 Diabetes

Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results

Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

First PCIs Preceded by Many Modifiable Risk Factors: Registry Data

June 2021 News Roundup

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Finerenone Cuts CV Events in CKD Patients With Diabetes: FIGARO-DKD

Prediabetes Linked to Higher MACE Risk

Social Determinants of Health Tied to Fewer COVID-19 Precautions in CVD Patients

In African-American Patients, Nontraditional Risk Factors Track With Early CAD

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

AHA Seeks to Drive Down Amputations 20% by 2030

Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk

Little Improvement Seen Over Two Decades in US Racial Health Disparities

Cardiometabolic Diseases Contribute to Bulk of COVID-19 Hospitalizations

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

High Glycemic Index Diets Linked to CVD and Mortality

Mom’s CV Health in Pregnancy Foretells Child’s Risk Years Later

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content